JSE slips as investors consider new Covid-19 vaccine developments
Vaccines may well be on the horizon, but investors are concerned as new restrictions keep on coming
17 November 2020 - 10:46
The JSE was weaker on Tuesday, with its global peers mixed as investors digest another Covid-19 vaccine announcement, while new restrictions are being implemented.
The stock markets received a boost on Monday after Moderna said that its preliminary phase 3 trial data showed its Covid-19 vaccine was more than 94% effective. Moderna’s announcement comes a week after Pfizer and BioNTech announced their vaccine trial results...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.